Renal replacement therapy and anticoagulation.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bailliere's Best Practice & Research. Clinical Anaesthesiology

• Publication date

  2017-08-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bpa.2017.08.005PMID 29248145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Continuous renal replacement therapy: a potential source of calories in the critically ill.

  2017cited by this paper
• Citrate pathophysiology and metabolism.

  2017cited by this paper
• Heparin-induced thrombocytopenia.

  2017cited by this paper
• Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: All Citrates Are Not Created Equal!

  2016cited by this paper
• A Comparison between Two Dilute Citrate Solutions (15 vs. 18 mmol/l) in Continuous Renal Replacement Therapy: The Base Excess and Renal Substitution Solution Study

  2016cited by this paper
• Transition From Heparin to Citrate Anticoagulation for Continuous Renal Replacement Therapy: Safety, Efficiency, and Cost

  2016cited by this paper
• Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials

  2016cited by this paper
• Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

  2015cited by this paper
• Ionized calcium measurements during regional citrate anticoagulation in CRRT: we need better blood gas analyzers

  2015cited by this paper
• A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults*

  2015cited by this paper
• Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs

  2015cited by this paper
• Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study

  2015cited by this paper
• Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial

  2015cited by this paper
• Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement

  2015cited by this paper
• Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate anticoagulation

  2015cited by this paper
• Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

  2014cited by this paper
• Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial

  2014cited by this paper
• Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.

  2014cited by this paper
• Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

  2014cited by this paper
• Repeated Premature Hemofilter Clotting During Regional Citrate Anticoagulation as Indicator of Heparin Induced Thrombocytopenia

  2014cited by this paper
• The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report

  2014cited by this paper
• Evaluation of acid-base control, electrolyte balance, and filter patency of a Prismaflex-based regional citrate anticoagulation protocol for pre-dilution continuous veno-venous hemodiafiltration.

  2014cited by this paper
• Maintaining Normal Levels of Ionized Calcium during Citrate-Based Renal Replacement Therapy Is Associated with Stable Parathyroid Hormone Levels

  2013cited by this paper
• Regional Citrate Anticoagulation for High Volume Continuous Venovenous Hemodialysis in Surgical Patients With High Bleeding Risk

  2013cited by this paper
• Regional citrate anticoagulation in critically ill patients with liver and kidney failure.

  2012cited by this paper
• Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients

  2012cited by this paper
• Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels

  2012cited by this paper
• Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.

  2012cited by this paper
• Solute clearance in CRRT: prescribed dose versus actual delivered dose.

  2012cited by this paper
• Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study

  2012cited by this paper
• Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution

  2012cited by this paper
• Regional Citrate Anticoagulation in Predilution Continuous Venovenous Hemofiltration Using Prismocitrate 10/2 Solution

  2012cited by this paper
• Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy.

  2012cited by this paper
• Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system*

  2011cited by this paper
• Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.

  2011cited by this paper
• Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Study

  2010cited by this paper
• Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically Ill

  2010cited by this paper
• The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications

  2010cited by this paper
• A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid–base status*

  2009cited by this paper
• Argatroban for anticoagulation in continuous renal replacement therapy*

  2009cited by this paper
• Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates

  2009cited by this paper
• THE CLINICAL APPLICATION OF CRRT—CURRENT STATUS: Anticoagulation for Continuous Renal Replacement Therapy

  2009cited by this paper
• Citrate anticoagulation for continuous venovenous hemofiltration*

  2009cited by this paper
• Renal replacement therapies: physiological review

  2008cited by this paper
• The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury

  2008cited by this paper
• Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study

  2007cited by this paper
• Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding.

  2007cited by this paper
• Intermittent versus continuous renal replacement therapy for acute renal failure in adults.

  2007cited by this paper
• The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT

  2007cited by this paper
• Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

  2006cited by this paper
• Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration.

  2006cited by this paper
• Filter Run Time in CVVH: Pre- versus Post-Dilution and Nadroparin versus Regional Heparin-Protamine Anticoagulation

  2005cited by this paper
• Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.

  2005cited by this paper
• Direct thrombin inhibitors.

  2005cited by this paper
• A Simple, Safe and Effective Citrate Anticoagulation Protocol for the Genius® Dialysis System in Acute Renal Failure

  2004cited by this paper
• Intermittent Hirudin Versus Continuous Heparin for Anticoagulation in Continuous Renal Replacement Therapy

  2004cited by this paper
• Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study

  2004cited by this paper
• Heparin Overview and Issues

  2004cited by this paper
• Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.

  2003cited by this paper
• Regional citrate anticoagulation in critically ill patients during continuous blood purification.

  2003cited by this paper
• Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients

  2003cited by this paper
• Antithrombin Attenuates Microvascular Leakage and Leukocyte-Endothelial Interaction in Response to Endotoxin

  2002cited by this paper
• Hirudin In Renal Insufficiency

  2002cited by this paper
• The Pharmacokinetics and Cardiovascular Effects of a Single Intravenous Dose of Protamine in Normal Volunteers

  2002cited by this paper
• High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial

  2001cited by this paper
• Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

  2001cited by this paper
• Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

  2001cited by this paper
• Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation

  2001cited by this paper
• Bleeding after intermittent or continuous r-hirudin during CVVH

  1999cited by this paper
• A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.

  1999cited by this paper
• The heparin-protamine interaction. A review.

  1999cited by this paper
• Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.

  1996cited by this paper
• Generation of antibodies to heparin‐PF4 complexes without thrombocytopenia in patients treated with unfractionated or low‐molecular‐weight heparin

  1996cited by this paper
• Calcium threshold in human plasma clotting kinetics.

  1994cited by this paper
• Prevalence of antithrombin deficiency in the healthy population

  1994cited by this paper
• Anticoagulant therapy in venous thromboembolism.

  1990cited by this paper
• Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients.

  1990cited by this paper
• 10 Anticoagulant therapy in venous thromboembolism

  1990cited by this paper
• Pharmacokinetics of Heparin and Low Molecular Weight Heparin Fragment (Fragmin®) in Rabbits with Impaired Renal or Metabolic Clearance

  1987cited by this paper
• ORIGINAL ARTICLE DOI: 10.3904/kjim.2011.26.1.68 Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ιll Patients Undergoing Continuous Venovenous

  year unknowncited by this paper

• Epurazione extrarenale in rianimazione

  2026cites this paper
• Thrombocytopenia in Continuous Kidney Replacement Therapy (CKRT): A Systematic Literature Review and Assessment of its Clinical Relevance

  2026cites this paper
• Comparison of unplanned treatment interruption during CRRT in ICU patients under CVVH (pre + post dilution) or CVVHDF (post‐dilution) mode: A retrospective cohort study

  2025cites this paper
• Efficacy and safety of low-molecular-weight-heparin plus citrate in nephrotic syndrome during continuous kidney replacement therapy: retrospective study

  2025cites this paper
• Anticoagulant regimens for different therapeutic plasma exchange modes

  2025cites this paper
• Épuration extrarénale en réanimation

  2025cites this paper
• Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study

  2024cites this paper
• Role of Tumor Microenvironment in the Risk of Thromboembolic Complications in Ovarian Cancer

  2024cites this paper
• Clinical guidance for unfractionated heparin dosing and monitoring in critically ill patients

  2024cites this paper
• Global Scientific Trends in Continuous Renal Replacement Therapy from 2000 to 2023: A Bibliometric and Visual Analysis

  2024cites this paper
• Influence of continuous renal replacement therapy on the plasma concentration of tigecycline in patients with septic shock: A prospective observational study

  2023cites this paper
• Quality indicators in prolonged hemodialysis with regional citrate anticoagulation with the genius system: retrospective cohort of critical patients with acute kidney injury

  2023cites this paper
• Application of Local Citrate Anticoagulation in Continuous Renal Replacement Therapy

  2023cites this paper
• Association of anticoagulation use during continuous kidney replacement therapy and 90-day outcomes: A multicentre study.

  2023cites this paper
• Bleeding during tooth extraction in patients with chronic kidney disease: A cross-sectional pilot study.

  2023cites this paper
• Extracorporeal Detoxification Methods and Hemostasis System for Ovarian Cancer Patients. Clinical Case

  2023cites this paper
• A Cohort Study on the Safety and Efficacy of Warfarin and Rivaroxaban in Anticoagulant Therapy in Patients with Atrial Fibrillation Study

  2022cites this paper
• Anticoagulación en circuitos de terapias continuas de reemplazo renal

  2022cites this paper
• Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.

  2022cites this paper
• Non‐anticoagulation pediatric continuous renal replacement therapy methods to increase circuit life

  2022cites this paper
• Double Pump Sequential Constant Citrate Anticoagulation in General Hemodialysis

  2022cites this paper
• Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy

  2021influential citation
• Measurement of the Concentration of Citrate in Human Biofluids in Patients Undergoing Continuous Renal Replacement Therapy Using Regional Citrate Anticoagulation: Application of a Two-Step Enzymatic Assay

  2021cites this paper
• A Meta-Analysis of Extracorporeal Anticoagulants in Pediatric Continuous Kidney Replacement Therapy

  2021cites this paper
• Influence of recombinant human-soluble thrombomodulin on extracorporeal circuit clotting in septic patients undergoing blood purification: a propensity-matched cohort study

  2021cites this paper
• Continuous renal replacement therapy in COVID-19—associated AKI: adding heparin to citrate to extend filter life—a retrospective cohort study

  2021cites this paper
• Continuous renal replacement therapy and extracorporeal membrane oxygenation: implications in the COVID-19 era

  2021cites this paper
• Comparison of the Clinical Effectiveness of AN69-oXiris versus AN69-ST Filter in Septic Patients: A Single-Centre Study

  2021cites this paper
• Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature

  2021cites this paper
• Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients

  2021cites this paper
• Recurrent Early Filter Clotting during Continuous Veno-Venous Hemodialysis with Regional Citrate Anticoagulation is Linked to Systemic Thrombin Generation and Heparin Induced Thrombocytopenia Type II: A Retrospective Analysis

  2021cites this paper
• Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta‐analysis of randomized controlled trials

  2021cites this paper
• A Prediction Model of Sufficient Filter Lifespan in Anticoagulation-free CRRT Patients

  2020cites this paper
• Continuous Renal Replacement Therapy: A Review

  2020influential citation
• Acute cardiorenal syndrome in acute heart failure: focus on renal replacement therapy

  2020cites this paper
• Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

  2020cites this paper
• Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases

  2020cites this paper
• Extracorporeal Filter and Circuit Patency: A Personalized Approach to Anticoagulation

  2020cites this paper
• Renal replacement anticoagulant management: Protocol and analysis plan for an observational comparative effectiveness study of linked data sources

  2020cites this paper
• Evaluation of continuous renal replacement therapy and risk factors in the pediatric intensive care unit

  2020cites this paper
• Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study

  2020cites this paper
• Feasibility and safety of combined cytokine adsorption and continuous veno-venous hemodialysis with regional citrate anticoagulation in patients with septic shock

  2020cites this paper
• Precision renal replacement therapy

  2020cites this paper
• Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which is the Best aPTT Sampling Site?

  2020cites this paper
• Application of regional citrate anticoagulation in membrane therapeutic plasma exchange

  2020cites this paper
• Renal replacement therapy: a practical update

  2019cites this paper
• Renal Replacement Therapy in Adult Patients After Cardiac Surgery.

  2019cites this paper
• Anticoagulation during continuous renal replacement therapy: An update

  2019cites this paper
• CRRT in the Septic Patient

  2018cites this paper
• [Anticoagulation for continuous renal replacement therapy in critically ill patients].

  2018cites this paper
• Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study

  2018cites this paper
• Regional citrate anticoagulation for continuous renal replacement therapy

  2018cites this paper
• A Prediction Model of Su�cient Filter Lifespan in Anticoagulation-free CRRT Patients

  year unknowncites this paper